| Vassallo P, Trohman R G. Prescribing amiodarone: An evidence-based review of clinical indications[J]. JAMA, 2007, 298(11): 1312-1322 |
| World Health Organization (WHO). WHO model list of essential medicines[R]. Geneva: WHO, 2015 |
| Zuo K, Li J, Li K B, et al. Disordered gut microbiota and alterations in metabolic patterns are associated with atrial fibrillation[J]. GigaScience, 2019, 8(6): giz058 |
| Eskes S A, Wiersinga W M. Amiodarone and thyroid[J]. Best Practice & Research Clinical Endocrinology & Metabolism, 2009, 23(6): 735-751 |
| Colunga Biancatelli R M, Congedo V, Calvosa L, et al. Adverse reactions of amiodarone[J]. Journal of Geriatric Cardiology, 2019, 16(7): 552-566 |
| Oliveira M, Melo N, Mota P C, et al. Pleuroparenchymal fibroelastosis as another potential lung toxicity pattern induced by amiodarone[J]. Archivos De Bronconeumologia, 2020, 56(1): 55-56 |
| Matuskova Z, Anzenbacherova E, Vecera R, et al. Administration of a probiotic can change drug pharmacokinetics: Effect of E. coli Nissle 1917 on amidarone absorption in rats[J]. PLoS One, 2014, 9(2): e87150 |
| Ingram D V, Jaggarao N S, Chamberlain D A. Ocular changes resulting from therapy with amiodarone[J]. The British Journal of Ophthalmology, 1982, 66(10): 676-679 |
| Raja K, Thung S N, Fiel M I, et al. Drug-induced steatohepatitis leading to cirrhosis: Long-term toxicity of amiodarone use[J]. Seminars in Liver Disease, 2009, 29(4): 423-428 |
| Farrell G C. Drugs and steatohepatitis[J]. Seminars in Liver Disease, 2002, 22(2): 185-194 |
| Lewis J H, Ranard R C, Caruso A, et al. Amiodarone hepatotoxicity: Prevalence and clinicopathologic correlations among 104 patients[J]. Hepatology, 1989, 9(5): 679-685 |
| Neshat S Y, Quiroz V M, Wang Y J, et al. Liver disease: Induction, progression, immunological mechanisms, and therapeutic interventions[J]. International Journal of Molecular Sciences, 2021, 22(13): 6777 |
| Hann A, Oo Y H, Perera M T P R. Regulatory T-cell therapy in liver transplantation and chronic liver disease[J]. Frontiers in Immunology, 2021, 12: 719954 |
| Duryee M J, Klassen L W, Thiele G M. Immunological response in alcoholic liver disease[J]. World Journal of Gastroenterology, 2007, 13(37): 4938-4946 |
| Berson A, De Beco V, Lettéron P, et al. Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes[J]. Gastroenterology, 1998, 114(4): 764-774 |
| Farrell G C. Drugs and steatohepatitis[J]. Seminars in Liver Disease, 2002, 22(2): 185-194 |
| Essrani R, Mehershahi S, Essrani R K, et al. Amiodarone-induced acute liver injury[J]. Case Reports in Gastroenterology, 2020, 14(1): 87-90 |
| Young T A, Cunningham C C, Bailey S M. Reactive oxygen species production by the mitochondrial respiratory chain in isolated rat hepatocytes and liver mitochondria: Studies using myxothiazol[J]. Archives of Biochemistry and Biophysics, 2002, 405(1): 65-72 |
| Serviddio G, Bellanti F, Giudetti A M, et al. Mitochondrial oxidative stress and respiratory chain dysfunction account for liver toxicity during amiodarone but not dronedarone administration[J]. Free Radical Biology and Medicine, 2011, 51(12): 2234-2242 |
| 赵圣刚, 陈善浆, 张冉, 等. 决奈达隆和胺碘酮对大鼠肝脏功能及组织的影响[J]. 中国心脏起搏与心电生理杂志, 2013, 27(5): 441-444 Zhao S G, Chen S J, Zhang R, et al. The effect of dronedarone and amiodarone on hepatic function and morphology in rats[J]. Chinese Journal of Cardiac Pacing and Electrophysiology, 2013, 27(5): 441-444(in Chinese) |
| Ernst M C, Sinal C J, Pollak P T. Influence of peroxisome proliferator-activated receptor-alpha (PPARα) activity on adverse effects associated with amiodarone exposure in mice[J]. Pharmacological Research, 2010, 62(5): 408-415 |
| Wu Q, Zhang X N, Zhao Y, et al. High l-carnitine ingestion impairs liver function by disordering gut bacteria composition in mice[J]. Journal of Agricultural and Food Chemistry, 2020, 68(20): 5707-5714 |
| Zhang P, Zheng L Y, Duan Y T, et al. Gut microbiota exaggerates triclosan-induced liver injury via gut-liver axis[J]. Journal of Hazardous Materials, 2022, 421: 126707 |
| Halder R C, Seki S, Weerasinghe A, et al. Characterization of NK cells and extrathymic T cells generated in the liver of irradiated mice with a liver shield[J]. Clinical and Experimental Immunology, 1998, 114(3): 434-447 |
| Blasco-Algora S, Masegosa-Ataz J, Gutiérrez-García M L, et al. Acute-on-chronic liver failure: Pathogenesis, prognostic factors and management[J]. World Journal of Gastroenterology, 2015, 21(42): 12125-12140 |
| Hensley M K, Deng J C. Acute on chronic liver failure and immune dysfunction: A mimic of sepsis[J]. Seminars in Respiratory and Critical Care Medicine, 2018, 39(5): 588-597 |
| Triantafyllou E, Woollard K J, McPhail M J W, et al. The role of monocytes and macrophages in acute and acute-on-chronic liver failure[J]. Frontiers in Immunology, 2018, 9: 2948 |
| Casulleras M, Zhang I W, López-Vicario C, et al. Leukocytes, systemic inflammation and immunopathology in acute-on-chronic liver failure[J]. Cells, 2020, 9(12): 2632 |
| Wandrer F, Frangež Ž, Liebig S, et al. Autophagy alleviates amiodarone-induced hepatotoxicity[J]. Archives of Toxicology, 2020, 94(10): 3527-3539 |
| Rhodes A, Eastwood J B, Smith S A. Early acute hepatitis with parenteral amiodarone: A toxic effect of the vehicle?[J]. Gut, 1993, 34(4): 565-566 |
| Lu J T, Jones A D, Harkema J R, et al. Amiodarone exposure during modest inflammation induces idiosyncrasy-like liver injury in rats: Role of tumor necrosis factor-alpha[J]. Toxicological Sciences: An Official Journal of the Society of Toxicology, 2012, 125(1): 126-133 |
| Meng X, Mojaverian P, Doedée M, et al. Bioavailability of amiodarone tablets administered with and without food in healthy subjects[J]. The American Journal of Cardiology, 2001, 87(4): 432-435 |
| Erez N, Hubel E, Avraham R, et al. Hepatic amiodarone lipotoxicity is ameliorated by genetic and pharmacological inhibition of endoplasmatic reticulum stress[J]. Toxicological Sciences: An Official Journal of the Society of Toxicology, 2017, 159(2): 402-412 |
| Rabinowich L, Shibolet O. Drug induced steatohepatitis: An uncommon culprit of a common disease[J]. BioMed Research International, 2015, 2015: 168905 |
| Vitins A P, Kienhuis A S, Speksnijder E N, et al. Mechanisms of amiodarone and valproic acid induced liver steatosis in mouse in vivo act as a template for other hepatotoxicity models[J]. Archives of Toxicology, 2014, 88(8): 1573-1588 |
| Fromenty B, Fisch C, Labbe G, et al. Amiodarone inhibits the mitochondrial beta-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice[J]. The Journal of Pharmacology and Experimental Therapeutics, 1990, 255(3): 1371-1376 |
| Soyama A, Hanioka N, Saito Y, et al. Amiodarone N-deethylation by CYP2C8 and its variants, CYP2C8*3 and CYP2C8 P404A[J]. Pharmacology & Toxicology, 2002, 91(4): 174-178 |
| Takai S, Oda S, Tsuneyama K, et al. Establishment of a mouse model for amiodarone-induced liver injury and analyses of its hepatotoxic mechanism[J]. Journal of Applied Toxicology, 2016, 36(1): 35-47 |
| Lee G R. The balance of Th17 versus Treg cells in autoimmunity[J]. International Journal of Molecular Sciences, 2018, 19(3): 730 |
| Guillot A, Tacke F. Liver macrophages: Old dogmas and new insights[J]. Hepatology Communications, 2019, 3(6): 730-743 |
| Elsegood C L, Chan C W, Degli-Esposti M A, et al. Kupffer cell-monocyte communication is essential for initiating murine liver progenitor cell-mediated liver regeneration[J]. Hepatology, 2015, 62(4): 1272-1284 |
| Castro G, Liu X J, Ngo K, et al. RORγt and RORα signature genes in human Th17 cells[J]. PLoS One, 2017, 12(8): e0181868 |
| Ciofani M, Madar A, Galan C, et al. A validated regulatory network for Th17 cell specification[J]. Cell, 2012, 151(2): 289-303 |
| Kocak M Z. Oral amiodarone-induced liver injury, especially gamma glutamyl transferase elevation: A case report[J]. Eurasian Journal of Medicine and Oncology, 2017, 2: 2 |
| Guigui B, Perrot S, Berry J P, et al. Amiodarone-induced hepatic phospholipidosis: A morphological alteration independent of pseudoalcoholic liver disease[J]. Hepatology, 1988, 8(5): 1063-1068 |
| Nguyen C L, Markey K A, Miltiadous O, et al. High-resolution analyses of associations between medications, microbiome, and mortality in cancer patients[J]. Cell, 2023, 186(12): 2705-2718.e17 |